The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) |
Placebo, Sulindac 400 MG |
Recruiting |
ASPirin Intervention for the REDuction of Colorectal Cancer Risk |
Placebo for Aspirin, Aspirin |
Active, not recruiting |
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps |
Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline |
Active, not recruiting |
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts |
Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture |
Active, not recruiting |
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection |
Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid |
Active, not recruiting |
Chemoprevention of Gastric Carcinogenesis |
Eflornithine, Eflornithine placebo |
Active, not recruiting |
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia |
Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment |
Active, not recruiting |
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study |
Biospecimen Collection, Lisinopril, Liver Ultrasonographic Elastography, Magnetic Resonance Elastography, Magnetic Resonance Imaging, Proton Density Fat Fraction, Questionnaire Administration |
Recruiting |
Obeticholic Acid for Prevention in Barrett's Esophagus |
Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic Acid, Placebo Administration, Questionnaire Administration |
Recruiting |
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis |
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Placebo Administration, Questionnaire Administration, Simvastatin |
Active, not recruiting |